GAMCO Investors’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

GAMCO Investors’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-19,400	Closed	-$468K	–	916
2023 Q1	$468K	Buy	+19,400	New	+$243K	0.01%	698

Other funds holding PRVB

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

GAMCO Investors's PRVB Position: Q2 2023 in Review

GAMCO Investors sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 19,400 shares — an estimated $468K sold.

GAMCO Investors first reported a position in PRVB in Q1 2023 and held it in 1 quarter. The position peaked at $468K in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

GAMCO Investors reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
GAMCO Investors sold 19,400 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $468K.
GAMCO Investors first reported a position in Provention Bio, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
GAMCO Investors's Provention Bio, Inc. Common Stock position peaked at $468K in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on GAMCO Investors's 13F filing for Q2 2023, filed 10 Aug 2023.